To see this page, please, enable javaScript and styleSheets on your browser: Tools -> Internet Options ...
Reload !
Gene TROVE2TABLE OF CONTENTS / OPEN CLOSE ALL PARAGRAPHS
Summary back to top
Compact gene diagram back to top
444 supporting clones for gene TROVE2 back to top
cDNA accession
Links to the sequence
Tissue

most 5' clones
in red
Match
mRNA
From bp
to bp
in mRNA
From bp
to bp
in accs.
Clone encodes
complete protein
(with AA variation)
Features Anomalies
detected by
AceView
Accession
match over
(% length)
Base differences
relative to genome
(% identity)
J04137   .a 1 to 1791 1 to 1792 R239K tiling clone,   1792/1792
(100 %)
2 diff
(99.9 %id)
TI_44348534   .b 1 to 754 130 to 879       757/884
(85 %)
39 diff
(95.6 %id)
BI560207 testis .b 1 to 754 7 to 756   tiling clone,   756/761
(99 %)
45 diff
(94.1 %id)
DA499783 brain .b 16 to 578 2 to 565   capped   564/564
(100 %)
1 diff
(99.9 %id)
AI929020 brain, frontal lobe .b 29 to 584 1 to 554   fully sequenced,   554/554
(100 %)
3 diff
(99.5 %id)
AW160738 brain, frontal lobe .b 29 to 647 1 to 616   tiling clone, fully sequenced,   616/616
(100 %)
6 diff
(99.1 %id)
NM_004600.5   .b 239 to 3478 1 to 3240 exact RefSeq, AAA Possibly primed on the genome, locally A rich (11/11 A in genome downstream of last aligned base) 3240/3240
(100 %)
0 diff
(100 %id)
BC036658 testis .b 399 to 3478 1 to 3082 exact tiling clone, available from MGC, AAA Possibly primed on the genome, locally A rich (11/11 A in genome downstream of last aligned base) 3082/3082
(100 %)
4 diff
(99.9 %id)
AI928857 brain, frontal lobe .b 557 to 1144 588 to 1   tiling clone, fully sequenced,   588/588
(100 %)
1 diff
(99.9 %id)
AW162240 brain, frontal lobe .b 618 to 1144 527 to 1   fully sequenced,   527/527
(100 %)
0 diff
(100 %id)
NM_001173524.1   .c 1 to 3245 2 to 3246 exact RefSeq, AAA Possibly primed on the genome, locally A rich (11/11 A in genome downstream of last aligned base) 3246/3246
(100 %)
0 diff
(100 %id)
DA518443 brain .c 1 to 536 2 to 537   tiling clone, capped   536/536
(100 %)
2 diff
(99.7 %id)
BJ990874 hepatoblastoma .c 38 to 623 1 to 586       586/586
(100 %)
0 diff
(100 %id)
BX402041   .c 45 to 956 1 to 909       909/909
(100 %)
4 diff
(99.6 %id)
DB059811 testis .c 63 to 562 2 to 501   capped   500/500
(100 %)
1 diff
(99.8 %id)
CA390199 eye, RPE/choroid .c 91 to 618 1 to 528       528/528
(100 %)
0 diff
(100 %id)
BP366430 thymus .c 136 to 715 1 to 580   tiling clone,   580/583
(99 %)
1 diff
(99.9 %id)
BP194750 brain .c 141 to 722 1 to 582       582/582
(100 %)
1 diff
(99.9 %id)
DB111832 thymus .c 161 to 745 2 to 588   capped   587/587
(100 %)
3 diff
(99.5 %id)
BM353900 Pancreas, Purified pancreatic islet .c 167 to 801 1 to 635       635/635
(100 %)
0 diff
(100 %id)
CD692206 normal nasopharynx .c 167 to 686 18 to 537       520/537
(96 %)
6 diff
(98.9 %id)
CD696220 normal nasopharynx .c 167 to 654 36 to 520       485/520
(93 %)
8 diff
(98.5 %id)
CD706310 normal nasopharynx .c 167 to 813 18 to 665       648/665
(97 %)
9 diff
(98.7 %id)
CD685555 normal nasopharynx .c 169 to 717 27 to 572       546/572
(95 %)
13 diff
(97.8 %id)
BX498133 Liver .c 170 to 493 1 to 324       324/324
(100 %)
0 diff
(100 %id)
DA750719   .c 172 to 742 2 to 572   capped   571/571
(100 %)
1 diff
(99.9 %id)
DA848148 placenta .c 173 to 738 2 to 567   capped   566/566
(100 %)
0 diff
(100 %id)
DA880977   .c 174 to 732 2 to 560   capped   559/559
(100 %)
0 diff
(100 %id)
AU139166 placenta .c 177 to 954 11 to 789   capped   779/832
(93 %)
5 diff
(99.4 %id)
DB217776 trachea .c 179 to 687 2 to 510   capped   509/509
(100 %)
1 diff
(99.9 %id)
CD695335 normal nasopharynx .c 182 to 708 34 to 558       525/558
(94 %)
7 diff
(98.8 %id)
BU663717 blood .c 182 to 827 9 to 654       646/654
(98 %)
7 diff
(99.0 %id)
DB030180 testis .c 186 to 744 2 to 563   capped   562/562
(100 %)
5 diff
(99.2 %id)
BP253374 Kidney .c 187 to 758 1 to 572       572/572
(100 %)
3 diff
(99.5 %id)
DA462910   .c 188 to 736 2 to 550   capped   549/549
(100 %)
0 diff
(100 %id)
BP229273 brain .c 190 to 771 1 to 582       582/582
(100 %)
0 diff
(100 %id)
BQ711761 Spleen .c 193 to 1103 1 to 924       918/924
(99 %)
29 diff
(96.9 %id)
CN256207 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells .c 197 to 870 1 to 675       675/675
(100 %)
3 diff
(99.6 %id)
BP231481 muscle .c 204 to 784 1 to 582       582/582
(100 %)
17 diff
(97.1 %id)
DA774507 brain .c 204 to 767 2 to 565   capped   564/564
(100 %)
3 diff
(99.5 %id)
CN256204 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .c 206 to 879 1 to 674       674/674
(100 %)
1 diff
(99.9 %id)
BU521773 leiomyosarcoma, uterus .c 210 to 956 1 to 752       752/874
(86 %)
9 diff
(99.0 %id)
BU664412 blood .c 212 to 883 24 to 694       671/694
(96 %)
7 diff
(99.0 %id)
AK314594 thalamus .c 213 to 1992 1 to 1780 exact tiling clone,   1780/1780
(100 %)
1 diff
(100.0 %id)
CD684488 normal nasopharynx .c 213 to 878 38 to 704       667/704
(94 %)
8 diff
(98.9 %id)
CD699134 normal nasopharynx .c 213 to 634 34 to 455       422/455
(92 %)
6 diff
(98.7 %id)
CD699646 normal nasopharynx .c 213 to 724 32 to 545       514/545
(94 %)
11 diff
(98.0 %id)
CD702533 normal nasopharynx .c 213 to 703 26 to 516       491/519
(94 %)
8 diff
(98.5 %id)
BU664408 blood .c 213 to 810 9 to 606       598/606
(98 %)
6 diff
(99.1 %id)
BU665029 blood .c 213 to 891 11 to 689       679/689
(98 %)
6 diff
(99.2 %id)
DR000392 fetal brain .c 213 to 968 7 to 764       758/764
(99 %)
3 diff
(99.7 %id)
DA416333 thalamus .c 214 to 775 2 to 563   capped   562/562
(100 %)
0 diff
(100 %id)
CD708963 normal nasopharynx .c 214 to 529 15 to 329       315/329
(95 %)
4 diff
(98.8 %id)
BP220623 colon .c 215 to 787 1 to 573       573/573
(100 %)
5 diff
(99.2 %id)
DA593941 lung .c 215 to 763 2 to 550   capped   549/549
(100 %)
0 diff
(100 %id)
S57803   .c 215 to 390 1 to 176       176/176
(100 %)
5 diff
(97.2 %id)
BI521435 pooled pancreas and spleen .c 219 to 956 1 to 735       735/758
(96 %)
10 diff
(98.7 %id)
BU664969 blood .c 222 to 827 9 to 614       606/614
(98 %)
8 diff
(98.7 %id)
BI919247 brain .c 224 to 956 33 to 772       740/842
(87 %)
16 diff
(98.1 %id)
TI_57243794   .c 224 to 956 33 to 772       740/842
(87 %)
16 diff
(98.1 %id)
CD686696 normal nasopharynx .c 225 to 792 15 to 582       568/582
(97 %)
6 diff
(99.0 %id)
CV571160 cornea, eye .c 227 to 838 1 to 613       613/613
(100 %)
1 diff
(99.9 %id)
BP328130 prostata .c 228 to 738 1 to 511       511/580
(88 %)
27 diff
(95.4 %id)
DA546171   .c 229 to 808 2 to 581   capped   580/580
(100 %)
0 diff
(100 %id)
CD686388 normal nasopharynx .c 231 to 817 21 to 607       587/607
(96 %)
7 diff
(98.9 %id)
CD700002 normal nasopharynx .c 233 to 842 27 to 636       610/636
(95 %)
6 diff
(99.1 %id)
BP371610 testis .c 239 to 816 1 to 577       577/577
(100 %)
3 diff
(99.5 %id)
DA495674 brain .c 240 to 815 2 to 578   capped   577/577
(100 %)
1 diff
(99.9 %id)
DA282514 corpus callosum .c 241 to 810 2 to 571   capped   570/570
(100 %)
1 diff
(99.9 %id)
CN256206 embryonic stem cells, cell lines H1, H7, andH9 .c 241 to 800 1 to 560       560/560
(100 %)
2 diff
(99.7 %id)
BU663920 blood .c 243 to 827 12 to 592       581/592
(98 %)
6 diff
(99.0 %id)
DA902814   .c 244 to 809 2 to 567   capped   566/566
(100 %)
1 diff
(99.9 %id)
AA296547 umbilical vein .c 259 to 589 1 to 331       331/331
(100 %)
0 diff
(100 %id)
AW960266   .c 259 to 928 1 to 668       668/680
(98 %)
23 diff
(96.7 %id)
CX763096 Blastocyst, pluripotent cell line derived fromblastocyst inner cell mass .c 281 to 1040 30 to 789     Submitted on the opposite strand 760/790
(96 %)
6 diff
(99.3 %id)
DA000075   .c 450 to 1262 2 to 813   tiling clone, capped   812/819
(99 %)
2 diff
(99.8 %id)
BI522251 pooled pancreas and spleen .c 1175 to 2078 908 to 1       908/909
(99 %)
23 diff
(97.5 %id)
BJ990875 hepatoblastoma .c 1568 to 2107 540 to 1       540/540
(100 %)
1 diff
(99.9 %id)
DB379355 placenta .c 1589 to 2127 544 to 1   tiling clone,   544/573
(94 %)
22 diff
(96.2 %id)
DB294820   .c 1681 to 2118 447 to 10       438/492
(89 %)
7 diff
(98.6 %id)
NM_001042370.2   .d 1 to 2078 1 to 2078 exact RefSeq, AAA   2078/2078
(100 %)
0 diff
(100 %id)
AY205315   .d 184 to 2078 1 to 1892 K136R tiling clone,   1892/1892
(100 %)
4 diff
(99.8 %id)
BI025554 marrow .d 1571 to 1927 1 to 356       356/356
(100 %)
7 diff
(98.1 %id)
DW460777 Liver .d 1833 to 1948 20 to 135       116/135
(85 %)
6 diff
(95.6 %id)
FN109686 breast carcinoma .d 1883 to 1955 72 to 1     Submitted on the opposite strand 72/80
(90 %)
1 diff
(98.8 %id)
NM_001042369.2   .e 1 to 2037 1 to 2037 exact RefSeq, AAA   2037/2037
(100 %)
0 diff
(100 %id)
AI124597 brain, pooled frontal lobe .e 99 to 557 1 to 459   tiling clone, Submitted on the opposite strand 459/459
(100 %)
2 diff
(99.6 %id)
BG716918 testis .e 156 to 877 1 to 739       739/795
(92 %)
39 diff
(95.1 %id)
M25077   .e 184 to 2037 1 to 1851 exact tiling clone,   1851/1851
(100 %)
3 diff
(99.9 %id)
BX474382   .e 260 to 864 1 to 605       605/605
(100 %)
4 diff
(99.4 %id)
ES308252 beard hair, skin .e 268 to 424 1 to 157       157/157
(100 %)
1 diff
(99.4 %id)
R07099 liver and spleen .e 367 to 692 1 to 328       328/435
(75 %)
8 diff
(98.2 %id)
EL733127 mixed .e 371 to 1046 1 to 675       675/681
(99 %)
9 diff
(98.7 %id)
FN090409 breast carcinoma .e 383 to 434 53 to 1     Submitted on the opposite strand 53/53
(100 %)
1 diff
(98.2 %id)
BP339266 Spleen .e 544 to 1104 1 to 562       562/562
(100 %)
8 diff
(98.6 %id)
FN100924 breast carcinoma .e 566 to 661 96 to 1     Submitted on the opposite strand 96/96
(100 %)
1 diff
(99.0 %id)
DR422990 eye, Pterygium .e 585 to 1353 1 to 769       769/769
(100 %)
1 diff
(99.9 %id)
CK001398 brain/CNS, Bulk tissue from Human Spinal cord .e 705 to 1135 1 to 430       430/430
(100 %)
22 diff
(94.9 %id)
ES314948 occipital scalp hair, skin .e 713 to 875 1 to 163       163/163
(100 %)
0 diff
(100 %id)
BX391059   .e 736 to 1647 1 to 912       912/912
(100 %)
6 diff
(99.4 %id)
BP242833 Liver .e 889 to 1459 1 to 571       571/571
(100 %)
2 diff
(99.7 %id)
AA303827 aorta .e 901 to 1146 1 to 246       246/249
(98 %)
1 diff
(99.6 %id)
BE539986 cervix .e 907 to 1618 1 to 717       717/787
(91 %)
22 diff
(97.3 %id)
BF973703 leiomyosarcoma cell line, uterus .e 990 to 1762 1 to 767       767/989
(77 %)
14 diff
(98.6 %id)
BG675030 skin .e 990 to 1838 1 to 849       849/855
(99 %)
11 diff
(98.8 %id)
BE177694 head_neck .e 1020 to 1687 23 to 687       665/716
(92 %)
13 diff
(98.2 %id)
BE177693 head_neck .e 1021 to 1687 15 to 673       659/684
(96 %)
18 diff
(97.4 %id)
BI856649 breast, mammary adenocarcinoma, cell line .e 1035 to 1834 1 to 802       802/873
(91 %)
11 diff
(98.8 %id)
TI_57188601   .e 1035 to 1834 59 to 860       802/873
(91 %)
11 diff
(98.8 %id)
BM007595 Spleen .e 1093 to 1875 1 to 783       783/783
(100 %)
6 diff
(99.3 %id)
TI_59382827   .e 1093 to 1875 62 to 844       783/783
(100 %)
6 diff
(99.3 %id)
BF571304 melanotic melanoma, high MDR, skin .e 1119 to 1839 1 to 732       689/739
(93 %)
43 diff
(94.2 %id)
BM955936 tonsil .e 1251 to 1627 1 to 377       377/377
(100 %)
0 diff
(100 %id)
BE005419 breast_normal .e 1299 to 1648 349 to 1     Submitted on the opposite strand 349/401
(87 %)
4 diff
(99.1 %id)
AW892529 nervous_normal .e 1466 to 1772 13 to 325       313/325
(96 %)
14 diff
(95.7 %id)
AA363530 Bone .e 1487 to 1775 1 to 292       292/295
(98 %)
5 diff
(98.4 %id)
BI025543 marrow .e 1585 to 1918 1 to 335       335/335
(100 %)
1 diff
(99.8 %id)
BI025555 marrow .e 1585 to 1920 1 to 334       334/334
(100 %)
3 diff
(99.2 %id)
DW460436 Liver .e 1627 to 1749 16 to 138       123/138
(89 %)
6 diff
(95.7 %id)
FN096840 breast carcinoma .e 1701 to 1776 78 to 1     Submitted on the opposite strand 78/81
(96 %)
2 diff
(97.6 %id)
FN163715 breast carcinoma .e 1701 to 1785 85 to 1     Submitted on the opposite strand 85/88
(96 %)
2 diff
(97.8 %id)
FN159514 breast carcinoma .e 1738 to 1826 89 to 1     Submitted on the opposite strand 89/89
(100 %)
1 diff
(98.9 %id)
AA903002 leiomyosarcoma, soft tissue .e 1912 to 2035 124 to 1       124/124
(100 %)
0 diff
(100 %id)
AA923022 pooled germ cell tumors .e 1912 to 2035 124 to 1       124/124
(100 %)
0 diff
(100 %id)
AA954984 pooled .e 1912 to 2035 124 to 1       124/124
(100 %)
0 diff
(100 %id)
NM_001173525.1   .f 1 to 2089 1 to 2089 exact RefSeq, AAA   2089/2089
(100 %)
0 diff
(100 %id)
AY205314   .f 184 to 2089 1 to 1903 K136R tiling clone,   1903/1903
(100 %)
4 diff
(99.8 %id)
NR_033393.1   .g 1 to 2644 2 to 2645 exact RefSeq, tiling clone, AAA Possibly primed on the genome, locally A rich (11/11 A in genome downstream of last aligned base) 2645/2645
(100 %)
0 diff
(100 %id)
BP234202 coronary artery .g 32 to 612 1 to 582       582/582
(100 %)
3 diff
(99.5 %id)
CR996095 T-Lymphocytes .g 177 to 935 1 to 759       759/765
(99 %)
3 diff
(99.7 %id)
BY799772 eye .g 185 to 797 1 to 613       613/613
(100 %)
0 diff
(100 %id)
DW413514 Liver .g 188 to 489 18 to 320       303/320
(94 %)
8 diff
(97.5 %id)
AU280515   .g 190 to 748 1 to 559       559/559
(100 %)
1 diff
(99.9 %id)
CD692100 normal nasopharynx .g 194 to 821 31 to 658       628/658
(95 %)
6 diff
(99.1 %id)
CN256203 embryonic stem cells, DMSO-treated H9 cellline .g 202 to 761 1 to 560       560/560
(100 %)
3 diff
(99.5 %id)
AK024044   .g 207 to 1870 552 to 2214   available from FLJ,   1663/2219
(74 %)
10 diff
(99.6 %id)
CD694945 normal nasopharynx .g 217 to 786 20 to 589       570/589
(96 %)
10 diff
(98.4 %id)
BG422289 Kidney, renal cell adenocarcinoma .g 233 to 957 1 to 743       703/823
(85 %)
32 diff
(96.2 %id)
BE409278 choriocarcinoma, placenta .g 248 to 925 1 to 684       684/761
(89 %)
15 diff
(98.1 %id)
AV736918 cord Blood .g 333 to 866 44 to 559       520/615
(84 %)
33 diff
(94.7 %id)
CR616562 fetal brain .g 604 to 1557 1 to 954       954/954
(100 %)
0 diff
(100 %id)
AL538601 brain, fetal brain .g 604 to 1556 1 to 952       952/952
(100 %)
7 diff
(99.3 %id)
BX445026 brain, fetal brain .g 604 to 1493 889 to 1       889/889
(100 %)
17 diff
(98.1 %id)
BX464024 brain, fetal brain .g 604 to 1526 1 to 922   AAA Possibly primed on the genome, locally A rich (12/12 A in genome downstream of last aligned base) 922/922
(100 %)
5 diff
(99.5 %id)
TI_159695253   .g 754 to 1526 903 to 141   AAA Possibly primed on the genome, locally A rich (12/12 A in genome downstream of last aligned base) 763/949
(80 %)
22 diff
(97.7 %id)
AI927967 Kidney .g 802 to 1526 747 to 22   AAA Possibly primed on the genome, locally A rich (12/12 A in genome downstream of last aligned base) 726/731
(99 %)
18 diff
(97.6 %id)
BE673350 Prostate .g 859 to 1531 671 to 1       671/682
(98 %)
8 diff
(98.9 %id)
TI_1948239524   .g 866 to 1394 1120 to 598     Submitted on the opposite strand 523/1359
(38 %)
15 diff
(98.9 %id)
BE501068 pooled germ cell tumors .g 876 to 1530 655 to 1       655/655
(100 %)
12 diff
(98.2 %id)
H65018 nose, olfactory epithelium .g 877 to 1092 1 to 221       221/315
(70 %)
5 diff
(98.5 %id)
BF589718 sciatic nerve .g 894 to 1526 656 to 24   AAA Possibly primed on the genome, locally A rich (12/12 A in genome downstream of last aligned base) 633/633
(100 %)
1 diff
(99.9 %id)
BM353625 Pancreas, Purified pancreatic islet .g 909 to 1525 617 to 1       617/617
(100 %)
0 diff
(100 %id)
AW129701 serous papillary carcinoma, high grade, 2pooled tumors, uterus .g 911 to 1530 620 to 1       620/620
(100 %)
7 diff
(98.9 %id)
AA669913 bone marrow stroma .g 912 to 1524 607 to 1       607/612
(99 %)
12 diff
(98.1 %id)
TI_1948239808   .g 917 to 1394 1067 to 597     Submitted on the opposite strand 471/1349
(34 %)
27 diff
(98.0 %id)
EB361667 eye, lens .g 918 to 1514 597 to 1       597/597
(100 %)
1 diff
(99.9 %id)
TI_1948239232   .g 977 to 1394 1029 to 606     Submitted on the opposite strand 424/1391
(30 %)
19 diff
(98.7 %id)
TI_1948239233   .g 977 to 1394 1016 to 598     Submitted on the opposite strand 419/1082
(38 %)
10 diff
(99.1 %id)
TI_1948239525   .g 977 to 1394 1016 to 598     Submitted on the opposite strand 419/1079
(38 %)
15 diff
(98.7 %id)
TI_1948240108   .g 977 to 1394 1008 to 592     Submitted on the opposite strand 417/1403
(29 %)
10 diff
(99.3 %id)
AW800365 uterus .g 978 to 1404 428 to 1       428/451
(94 %)
6 diff
(98.7 %id)
BI020445 marrow .g 983 to 1403 12 to 432       421/432
(97 %)
7 diff
(98.4 %id)
BF000774 malignant melanoma, metastatic to lymphnode, skin .g 987 to 1526 535 to 1       535/535
(100 %)
11 diff
(98.0 %id)
BI024321 marrow .g 992 to 1372 44 to 433       390/433
(90 %)
23 diff
(94.7 %id)
AL597323   .g 993 to 1489 1 to 497       497/497
(100 %)
0 diff
(100 %id)
BE178909 head_neck .g 1005 to 1385 381 to 1     Submitted on the opposite strand 381/381
(100 %)
7 diff
(98.2 %id)
C75106   .g 1006 to 1526 533 to 14   AAA Possibly primed on the genome, locally A rich (12/12 A in genome downstream of last aligned base) 520/521
(99 %)
6 diff
(98.9 %id)
AI583102 adenocarcinoma, Pancreas .g 1013 to 1526 515 to 1       515/515
(100 %)
25 diff
(95.2 %id)
AW291500   .g 1015 to 1526 530 to 18   AAA Possibly primed on the genome, locally A rich (12/12 A in genome downstream of last aligned base) 513/513
(100 %)
3 diff
(99.5 %id)
TI_1948240109   .g 1016 to 1394 982 to 600     Submitted on the opposite strand 383/1110
(34 %)
12 diff
(99.0 %id)
AA639906   .g 1017 to 1526 532 to 27   AAA Possibly primed on the genome, locally A rich (12/12 A in genome downstream of last aligned base) 506/509
(99 %)
11 diff
(97.9 %id)
BF818439 colon_ins .g 1032 to 1459 428 to 1     Submitted on the opposite strand 428/428
(100 %)
8 diff
(98.2 %id)
AA075181   .g 1054 to 1519 1 to 474   fully sequenced,   474/474
(100 %)
10 diff
(97.9 %id)
AI149856   .g 1066 to 1498 451 to 19   AAA Possibly primed on the genome, locally A rich (17/17 A in genome downstream of last aligned base) 433/442
(97 %)
3 diff
(99.4 %id)
AI652374 pooled germ cell tumors .g 1076 to 1530 455 to 1       455/455
(100 %)
0 diff
(100 %id)
DN913438   .g 1078 to 1724 1 to 643       643/643
(100 %)
9 diff
(98.7 %id)
AI968290 pooled germ cell tumors .g 1078 to 1530 453 to 1       453/453
(100 %)
0 diff
(100 %id)
AI470734 lymph node, lymphoma, follicular mixed small and largecell .g 1085 to 1526 441 to 1       441/524
(84 %)
5 diff
(99.1 %id)
BQ937892 leiomyosarcoma, uterus .g 1085 to 1967 36 to 922       887/924
(95 %)
28 diff
(97.0 %id)
TI_1948239809   .g 1094 to 1394 899 to 593     Submitted on the opposite strand 307/1134
(27 %)
16 diff
(98.6 %id)
AA659632   .g 1095 to 1535 442 to 1       442/442
(100 %)
4 diff
(99.1 %id)
AW303492 pooled .g 1099 to 1499 406 to 6       401/406
(98 %)
0 diff
(100 %id)
AW511040 pooled .g 1099 to 1499 406 to 6       401/406
(98 %)
0 diff
(100 %id)
AI936037 poorly differentiated adenocarcinoma withsignet ring cell features, stomach .g 1101 to 1526 426 to 1       426/426
(100 %)
27 diff
(93.7 %id)
AI001865   .g 1114 to 1658 537 to 1       537/537
(100 %)
9 diff
(98.4 %id)
T27656 colon, endothelial .g 1137 to 1526 390 to 1       390/390
(100 %)
3 diff
(99.3 %id)
AA968959 Kidney, kidney tumor .g 1139 to 1470 332 to 1       332/332
(100 %)
0 diff
(100 %id)
AW079181 colon, juvenile granulosa tumor .g 1146 to 1526 381 to 1       381/382
(99 %)
7 diff
(98.2 %id)
N31697 melanocyte .g 1168 to 1517 1 to 350       350/350
(100 %)
0 diff
(100 %id)
AW105053 pooled .g 1174 to 1499 331 to 6       326/331
(98 %)
0 diff
(100 %id)
BI020439 marrow .g 1205 to 1686 481 to 4       478/481
(99 %)
0 diff
(100 %id)
H65019 nose, olfactory epithelium .g 1212 to 1525 324 to 5       320/324
(98 %)
3 diff
(99.1 %id)
BI253324 cervical carcinoma cell line, cervix .g 1213 to 1874 59 to 718       660/718
(91 %)
13 diff
(98.2 %id)
BI020440 marrow .g 1223 to 1676 464 to 12       453/464
(97 %)
1 diff
(99.8 %id)
BI020430 marrow .g 1232 to 1683 449 to 1       449/453
(99 %)
14 diff
(97.0 %id)
BF084360 colon .g 1234 to 1473 27 to 266       240/266
(90 %)
6 diff
(97.8 %id)
DW415087 Liver .g 1237 to 1524 20 to 307       288/314
(91 %)
5 diff
(98.5 %id)
AI567789 adenocarcinoma, Pancreas .g 1237 to 1537 301 to 1       301/301
(100 %)
1 diff
(99.7 %id)
BF084366 colon .g 1289 to 1474 1 to 190       190/190
(100 %)
12 diff
(93.7 %id)
AA075182   .g 1294 to 1528 235 to 1   fully sequenced,   235/235
(100 %)
0 diff
(100 %id)
AI985925 four pooled poorly-differentiatedadenocarcinomas, lung .g 1300 to 1526 227 to 1       227/227
(100 %)
0 diff
(100 %id)
AI984196 adenocarcinoma, Pancreas .g 1312 to 1543 242 to 10       233/242
(96 %)
0 diff
(100 %id)
AU160412.
matches multiple genes
  .g 1323 to 1870 548 to 6     also hits gene NBPF8.2 543/548
(99 %)
0 diff
(100 %id)
BG548649 lung .g 1331 to 1882 1 to 575       575/854
(67 %)
37 diff
(95.7 %id)
BI025546 marrow .g 1340 to 1682 344 to 1       344/344
(100 %)
13 diff
(96.3 %id)
AI217918   .g 1356 to 1651 309 to 14       296/309
(95 %)
0 diff
(100 %id)
FN128565 breast carcinoma .g 1377 to 1461 1 to 83       83/86
(96 %)
6 diff
(93.1 %id)
S57805   .g 1377 to 1494 1 to 118       118/127
(92 %)
1 diff
(99.3 %id)
BG026573 Bone, osteosarcoma, cell line .g 1386 to 2050 1 to 658       658/949
(69 %)
24 diff
(97.5 %id)
AA789019 parathyroid gland, parathyroid tumor .g 1400 to 1839 442 to 1       442/442
(100 %)
5 diff
(98.9 %id)
BE242520 leukopheresis .g 1412 to 1525 114 to 1       114/123
(92 %)
2 diff
(98.4 %id)
FN052414 breast carcinoma .g 1419 to 1508 1 to 90       90/90
(100 %)
2 diff
(97.8 %id)
N23197.
matches multiple genes
melanocyte .g 1433 to 1876 448 to 1     also hits gene UBE2V2 448/452
(99 %)
5 diff
(98.9 %id)
BE672229 pooled germ cell tumors .g 1437 to 1876 440 to 1       440/440
(100 %)
0 diff
(100 %id)
AI284136 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus .g 1475 to 1875 401 to 1       401/401
(100 %)
2 diff
(99.6 %id)
AI636818 Kidney, renal cell tumor .g 1479 to 1876 398 to 1       398/398
(100 %)
2 diff
(99.5 %id)
BI037840 nervous_tumor .g 1519 to 1953 439 to 6       434/440
(98 %)
0 diff
(100 %id)
AW137256   .g 1525 to 1876 369 to 18   AAA Possibly primed on the genome, locally A rich (11/11 A in genome downstream of last aligned base) 352/352
(100 %)
0 diff
(100 %id)
BG776322 lung, mucoepidermoid carcinoma .g 1542 to 2112 1 to 575       575/735
(78 %)
17 diff
(97.7 %id)
AA507378 breast .g 1543 to 1920 392 to 15   AAA Possibly primed on the genome, locally A rich (11/11 A in genome downstream of last aligned base) 378/378
(100 %)
1 diff
(99.8 %id)
AA954063 pooled .g 1555 to 1876 322 to 1       322/322
(100 %)
1 diff
(99.7 %id)
AI244726 Kidney .g 1559 to 1979 421 to 1       421/421
(100 %)
1 diff
(99.8 %id)
AA093699   .g 1647 to 1851 1 to 204       204/204
(100 %)
6 diff
(97.1 %id)
AA095715   .g 1649 to 1849 1 to 200       200/200
(100 %)
5 diff
(97.5 %id)
CR592331 Neuroblastoma Cot 25-normalized .h 1 to 1471 4 to 1474 exact tiling clone,   1474/1474
(100 %)
0 diff
(100 %id)
BX394323 Neuroblastoma Cot 25-normalized .h 27 to 756 25 to 754   fully sequenced,   730/754
(96 %)
7 diff
(99.1 %id)
BX394322 Neuroblastoma Cot 25-normalized .h 726 to 1471 749 to 1   fully sequenced,   749/749
(100 %)
7 diff
(99.1 %id)
BQ303178 breast .h 1346 to 1599 4 to 256       253/262
(96 %)
10 diff
(96.2 %id)
BE156142 head_neck .h 1353 to 1872 533 to 13   tiling clone, Submitted on the opposite strand 521/533
(97 %)
0 diff
(100 %id)
BF245564 brain, glioblastoma .h 1517 to 2221 1 to 700   tiling clone,   700/757
(92 %)
46 diff
(94.0 %id)
DN913437   .h 1709 to 2220 512 to 1       512/512
(100 %)
2 diff
(99.7 %id)
BU561573 testis .h 1735 to 2436 1 to 709   tiling clone,   709/781
(90 %)
8 diff
(99.0 %id)
BX114850 moderately-differentiated endometrialadenocarcinoma, 3 pooled tumors, uterus .h 1758 to 2220 477 to 15   AAA Possibly primed on the genome, locally A rich (11/11 A in genome downstream of last aligned base) 463/463
(100 %)
0 diff
(100 %id)
AA927317 pooled .h 1798 to 2220 422 to 1       422/422
(100 %)
1 diff
(99.8 %id)
AI536927 moderately-differentiated endometrialadenocarcinoma, 3 pooled tumors, uterus .h 1880 to 2220 341 to 1       341/341
(100 %)
2 diff
(99.5 %id)
AA001416 eye, retina .h 2123 to 2549 1 to 428   tiling clone, Submitted on the opposite strand 428/428
(100 %)
1 diff
(99.8 %id)
AA017466 eye, retina .h 2149 to 2581 1 to 440   tiling clone, Submitted on the opposite strand 440/441
(99 %)
11 diff
(97.6 %id)
BG494940 lung, mucoepidermoid carcinoma .h 2551 to 3084 40 to 572   tiling clone,   533/573
(93 %)
4 diff
(99.4 %id)
CB118009 brain .h 2715 to 2990 1 to 276   tiling clone,   276/277
(99 %)
6 diff
(97.9 %id)
FN112315 breast carcinoma .h 3006 to 3127 127 to 1     Submitted on the opposite strand 127/128
(99 %)
9 diff
(93.0 %id)
BX644242   .h 3027 to 3577 1 to 551   tiling clone,   551/551
(100 %)
1 diff
(99.9 %id)
EH323611   .h 3171 to 3239 1 to 69       69/69
(100 %)
0 diff
(100 %id)
AA074293 pineal gland .h 3252 to 3555 1 to 304   tiling clone,   304/304
(100 %)
0 diff
(100 %id)
EH346188   .h 3437 to 3511 1 to 75       75/75
(100 %)
0 diff
(100 %id)
AA017465 eye, retina .h 3503 to 3679 177 to 1   tiling clone, Submitted on the opposite strand 177/195
(90 %)
1 diff
(99.5 %id)
BX481144   .h 3556 to 4070 10 to 524   tiling clone,   515/524
(98 %)
11 diff
(98.0 %id)
BE176302 head_neck .h 3680 to 3953 8 to 279       272/279
(97 %)
6 diff
(97.9 %id)
DA253941 caudate nucleus .i 1 to 576 2 to 577   tiling clone, capped   576/576
(100 %)
1 diff
(99.9 %id)
DR422489 eye, Pterygium .i 132 to 778 1 to 647   tiling clone,   647/647
(100 %)
0 diff
(100 %id)
AA830890 germinal center B cell .i 763 to 1209 447 to 1   tiling clone,   447/447
(100 %)
1 diff
(99.8 %id)
AA017728 eye, retina .j 1 to 345 1 to 352   tiling clone,   352/352
(100 %)
9 diff
(97.5 %id)
BP206758 coronary artery .j 241 to 821 1 to 582   tiling clone,   582/582
(100 %)
3 diff
(99.5 %id)
BG215572   .k 1 to 814 1 to 807 Y161H K172X Q186K R187E V188F ... tiling clone,   807/809
(99 %)
26 diff
(96.8 %id)
FN061674 breast carcinoma .k 168 to 263 1 to 96       96/96
(100 %)
0 diff
(100 %id)
BF174873 blood .k 263 to 493 1 to 230       230/232
(99 %)
7 diff
(97.0 %id)
FN159496 breast carcinoma .k 327 to 437 1 to 115       115/115
(100 %)
5 diff
(95.7 %id)
BI021207 marrow .k 385 to 728 349 to 3   tiling clone,   347/349
(99 %)
10 diff
(97.2 %id)
FN073190 breast carcinoma .k 515 to 623 110 to 1   tiling clone, Submitted on the opposite strand 110/110
(100 %)
2 diff
(98.2 %id)
FN116309 breast carcinoma .k 623 to 723 100 to 1     Submitted on the opposite strand 100/108
(92 %)
4 diff
(96.3 %id)
BQ948490 sciatic nerve .l-u 1 to 608 1 to 616   tiling clone,   616/982
(62 %)
18 diff
(98.2 %id)
AK130037 Kidney .l-u 269 to 2381 1 to 2113 exact tiling clone, available from FLJ,   2113/2113
(100 %)
1 diff
(100.0 %id)
CD244754 White Matter .l-u 690 to 1576 902 to 9     Submitted on the opposite strand 894/916
(97 %)
0 diff
(100 %id)
AA010351 liver and spleen .l-u 1078 to 1327 1 to 252       252/252
(100 %)
1 diff
(99.7 %id)
AI539818 serous papillary carcinoma, high grade, 2pooled tumors, uterus .l-u 1415 to 1943 524 to 1       524/528
(99 %)
16 diff
(97.0 %id)
AA010352 liver and spleen .l-u 2141 to 2381 241 to 1       241/241
(100 %)
0 diff
(100 %id)
BI559880 testis .m 1 to 701 1 to 700 L189W G190V S191V I192Y L193S ... tiling clone,   700/700
(100 %)
4 diff
(99.5 %id)
TI_44348360   .m 1 to 701 115 to 814 L189W G190V S191V I192Y L193S ...     700/814
(85 %)
7 diff
(99.2 %id)
TI_57173820   .m 41 to 699 30 to 687 L75C L76Y Q77K E78K M79C ...     658/688
(95 %)
10 diff
(98.6 %id)
BI825976 brain, medulla .m 42 to 699 1 to 657 L75C L76Y Q77K E78K M79C ...     657/658
(99 %)
4 diff
(99.4 %id)
BU570553 testis .n 1 to 739 1 to 750 K165* tiling clone,   748/822
(90 %)
19 diff
(97.7 %id)
EL954283 eyeball .o 1 to 490 54 to 541 Q2H H3P P4G G5S S6R ... tiling clone,   488/541
(90 %)
9 diff
(98.4 %id)
DA590406 lung .o 64 to 598 2 to 537   capped   536/539
(99 %)
2 diff
(99.7 %id)
CX761715 Blastocyst, pluripotent cell line derived fromblastocyst inner cell mass .o 106 to 783 1 to 678   tiling clone, Submitted on the opposite strand 678/799
(84 %)
2 diff
(99.8 %id)
DB031478 testis .o 129 to 740 2 to 613   capped   612/612
(100 %)
0 diff
(100 %id)
DA246676 brain .p 1 to 591 2 to 592 exact tiling clone, capped   591/591
(100 %)
0 diff
(100 %id)
TI_59393322   .p 547 to 1376 74 to 908   tiling clone,   835/835
(100 %)
25 diff
(97.1 %id)
BM015198 breast, mammary adenocarcinoma, cell line .p 549 to 1376 1 to 833   tiling clone,   833/833
(100 %)
25 diff
(97.0 %id)
BX504165   .q-u 1 to 555 43 to 601   tiling clone,   559/601
(93 %)
3 diff
(99.6 %id)
R07714 liver and spleen .q-u 34 to 320 1 to 285     Submitted on the opposite strand 285/285
(100 %)
4 diff
(98.6 %id)
AL597267   .q-u 53 to 468 1 to 421       421/421
(100 %)
5 diff
(98.9 %id)
DA235559 brain .q-u 179 to 760 2 to 583   capped   582/582
(100 %)
0 diff
(100 %id)
AL705857 human skeletal muscle .q-u 181 to 1035 1 to 857 exact     857/860
(99 %)
11 diff
(98.8 %id)
DA405088 thalamus .q-u 204 to 760 2 to 560   capped   559/559
(100 %)
3 diff
(99.5 %id)
DB157086 thymus .q-u 214 to 787 2 to 575 exact tiling clone, capped   574/574
(100 %)
0 diff
(100 %id)
DB220768 trachea .q-u 230 to 576 2 to 349   capped   348/348
(100 %)
1 diff
(99.8 %id)
AW505428 lymph .q-u 308 to 678 8 to 378       371/379
(97 %)
3 diff
(99.3 %id)
TI_154161990   .q-u 308 to 881 82 to 655 V5G M17K L23H L37F L40R ...     574/716
(80 %)
30 diff
(95.9 %id)
DB081673 testis .q-u 369 to 932 2 to 566 L23H tiling clone, capped   565/565
(100 %)
2 diff
(99.7 %id)
BF805048 colon_ins .q-u 521 to 714 1 to 197       197/197
(100 %)
8 diff
(96.0 %id)
EH316554   .q-u 568 to 639 1 to 70       70/70
(100 %)
2 diff
(97.2 %id)
BG498806 adenocarcinoma, Prostate .q-u 908 to 1573 1 to 676   tiling clone,   676/722
(93 %)
21 diff
(97.1 %id)
DA473128   .q-u 954 to 1495 2 to 545   capped   544/544
(100 %)
3 diff
(99.5 %id)
AI368006 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus .q-u 955 to 1436 485 to 2       484/485
(99 %)
0 diff
(100 %id)
CD652162 Embryonic Stem cells .q-u 972 to 1740 12 to 776       765/791
(96 %)
5 diff
(99.4 %id)
DA946669 Spleen .q-u 1061 to 1631 2 to 576   capped   575/575
(100 %)
4 diff
(99.4 %id)
BF886967 testis_normal .q-u 1072 to 1311 1 to 237       237/237
(100 %)
9 diff
(96.3 %id)
AK022030 whole embryo, mainly body .q-u 1082 to 3612 1 to 2527   tiling clone, available from FLJ,   2527/2527
(100 %)
3 diff
(99.9 %id)
AU120647 whole embryo, mainly body .q-u 1083 to 1827 2 to 740   capped   739/739
(100 %)
6 diff
(99.2 %id)
AL601038   .q-u 1115 to 1816 1 to 705       705/705
(100 %)
3 diff
(99.6 %id)
CK001459 brain/CNS, Bulk tissue from Human Spinal cord .q-u 1192 to 1837 1 to 648       648/648
(100 %)
3 diff
(99.6 %id)
BX645698   .q-u 1195 to 1762 1 to 565       565/565
(100 %)
2 diff
(99.7 %id)
DB013970 esophageal, tumor tissue .q-u 1198 to 1765 2 to 572   capped   571/571
(100 %)
3 diff
(99.5 %id)
CN360121 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells .q-u 1199 to 1871 1 to 673       673/673
(100 %)
4 diff
(99.5 %id)
DB255494 uterus .q-u 1225 to 1798 2 to 575   capped   574/574
(100 %)
2 diff
(99.7 %id)
DA472077   .q-u 1236 to 1988 2 to 755   tiling clone, capped   754/781
(96 %)
9 diff
(98.9 %id)
CB963903 Blood vessels - aorta, basilar and artery .q-u 1260 to 1991 1 to 738       738/760
(97 %)
18 diff
(97.7 %id)
DA419170 cord Blood .q-u 1272 to 1816 2 to 546   capped   545/545
(100 %)
0 diff
(100 %id)
DA954981 Spleen .q-u 1285 to 1832 2 to 549   capped   548/548
(100 %)
0 diff
(100 %id)
DA496750 brain .q-u 1308 to 1868 2 to 562   capped   561/561
(100 %)
0 diff
(100 %id)
DA886997   .q-u 1319 to 1878 2 to 561   capped   560/560
(100 %)
0 diff
(100 %id)
CB267320 adipose .q-u 1334 to 1646 1 to 313       313/313
(100 %)
0 diff
(100 %id)
DA523238 brain .q-u 1404 to 1899 2 to 498   capped   497/499
(99 %)
2 diff
(99.6 %id)
DA517069 brain .q-u 1421 to 1954 2 to 535   capped   534/534
(100 %)
3 diff
(99.5 %id)
DA689218   .q-u 1437 to 1964 2 to 527   capped   526/526
(100 %)
2 diff
(99.7 %id)
DA161433 amygdala .q-u 1479 to 2037 2 to 560   capped   559/559
(100 %)
3 diff
(99.5 %id)
CX868071 embryonic stem .q-u 1483 to 2109 12 to 637     Submitted on the opposite strand 626/637
(98 %)
6 diff
(99.1 %id)
DA752064   .q-u 1532 to 2102 2 to 573   capped   572/572
(100 %)
1 diff
(99.9 %id)
DB272897 uterus .q-u 1532 to 2077 2 to 548   capped   547/547
(100 %)
1 diff
(99.9 %id)
DA360739 subthalamic nucleus .q-u 1591 to 2142 2 to 558   capped   557/557
(100 %)
6 diff
(99.0 %id)
BG682477 skin, squamous cell carcinoma .q-u 1678 to 2330 22 to 683       662/885
(74 %)
25 diff
(97.2 %id)
AL708295 human skeletal muscle .q-u 1692 to 2230 1 to 539       539/539
(100 %)
1 diff
(99.9 %id)
BQ879470 dorsal root ganglia .q-u 1785 to 2612 1 to 835   tiling clone,   835/941
(88 %)
12 diff
(98.8 %id)
BE784085 eye, retinoblastoma .q-u 1884 to 2666 1 to 770       770/929
(82 %)
27 diff
(97.1 %id)
BE884836 leiomyosarcoma, uterus .q-u 1933 to 2687 1 to 753       753/934
(80 %)
29 diff
(96.9 %id)
BU949361 Pancreas, Purified pancreatic islet .q-u 1947 to 2381 1 to 435       435/435
(100 %)
8 diff
(98.2 %id)
DB277037 uterus .q-u 1962 to 2332 2 to 372   capped   371/371
(100 %)
0 diff
(100 %id)
CK902759 Pancreas, Purified pancreatic islet .q-u 1965 to 2506 1 to 542     Submitted on the opposite strand 542/542
(100 %)
0 diff
(100 %id)
DA078249 cerebellum .q-u 1968 to 2540 2 to 574   capped   573/573
(100 %)
1 diff
(99.9 %id)
BF170664 blood .q-u 1991 to 2328 1 to 337       337/337
(100 %)
5 diff
(98.6 %id)
FN086703 breast carcinoma .q-u 2029 to 2133 105 to 1     Submitted on the opposite strand 105/105
(100 %)
0 diff
(100 %id)
BG536989 lung .q-u 2047 to 2662 1 to 634       634/634
(100 %)
40 diff
(93.7 %id)
BQ440618 melanotic melanoma, skin .q-u 2047 to 2873 12 to 841       830/844
(98 %)
8 diff
(99.1 %id)
BF589324 pooled .q-u 2139 to 2710 1 to 572     Submitted on the opposite strand 572/572
(100 %)
2 diff
(99.7 %id)
CF454715 peripheral nervous system .q-u 2150 to 2899 1 to 750       750/750
(100 %)
0 diff
(100 %id)
CB986015 Pooled-Glandular .q-u 2161 to 2809 1 to 657       657/723
(90 %)
16 diff
(97.8 %id)
W20296 lung .q-u 2215 to 2664 1 to 454       454/454
(100 %)
6 diff
(98.7 %id)
BQ226907 embryonal carcinoma, cell line, testis .q-u 2226 to 3036 1 to 818       818/896
(91 %)
9 diff
(99.0 %id)
C04336 heart .q-u 2233 to 2630 1 to 398       398/398
(100 %)
1 diff
(99.8 %id)
C05469 heart .q-u 2233 to 2522 1 to 290       290/290
(100 %)
0 diff
(100 %id)
BX326969   .q-u 2273 to 2875 1 to 603       603/606
(99 %)
13 diff
(97.9 %id)
CB109091 Liver .q-u 2325 to 2742 1 to 418       418/418
(100 %)
2 diff
(99.6 %id)
BX110561 placenta .q-u 2358 to 3205 36 to 883       848/883
(96 %)
6 diff
(99.4 %id)
R24166 placenta .q-u 2358 to 2788 1 to 442       442/444
(99 %)
23 diff
(94.9 %id)
R24099 placenta .q-u 2358 to 2582 1 to 227       227/234
(97 %)
3 diff
(98.8 %id)
BG402748 bladder, transitional cell papilloma, cell line .q-u 2364 to 3195 12 to 842       831/1021
(81 %)
51 diff
(95.1 %id)
D78896 placenta .q-u 2370 to 2570 1 to 201       201/201
(100 %)
2 diff
(99.1 %id)
AL119057 amygdala .q-u 2371 to 2682 1 to 313       313/315
(99 %)
2 diff
(99.4 %id)
BG617310 Liver .q-u 2384 to 3097 1 to 714       714/714
(100 %)
5 diff
(99.3 %id)
BF574802 muscle (skeletal) .q-u 2394 to 3034 1 to 634       634/894
(70 %)
30 diff
(96.7 %id)
TI_57241421   .q-u 2422 to 3300 30 to 899       870/903
(96 %)
18 diff
(98.1 %id)
BI913658 brain .q-u 2428 to 3300 1 to 865       865/869
(99 %)
17 diff
(98.1 %id)
CK003462 brain/CNS, Human Brain - Cerebellar Cortex .q-u 2441 to 3065 1 to 621       621/655
(94 %)
6 diff
(99.1 %id)
D81952 brain .q-u 2454 to 2717 1 to 264       264/264
(100 %)
1 diff
(99.7 %id)
FN151325 breast carcinoma .q-u 2481 to 2593 1 to 112       112/112
(100 %)
7 diff
(93.8 %id)
AA058376 uterus .q-u 2528 to 3052 1 to 533       533/582
(91 %)
11 diff
(98.2 %id)
CN360120 embryonic stem cells, DMSO-treated H9 cellline .q-u 2529 to 3167 1 to 639       639/639
(100 %)
0 diff
(100 %id)
BX324492.
matches multiple genes
Neuroblastoma Cot 25-normalized .q-u 2551 to 3589 1033 to 1     also hits gene NBLA00301 1033/1033
(100 %)
31 diff
(97.0 %id)
FN079579 breast carcinoma .q-u 2560 to 2682 123 to 1     Submitted on the opposite strand 123/123
(100 %)
1 diff
(99.2 %id)
BM831818 stomach .q-u 2569 to 2756 1 to 190       190/190
(100 %)
6 diff
(96.9 %id)
CB129021 Liver .q-u 2659 to 3264 1 to 606       606/606
(100 %)
0 diff
(100 %id)
EB386283 eye, optic nerve .q-u 2698 to 3373 1 to 677       677/677
(100 %)
3 diff
(99.6 %id)
DB540051.
matches multiple genes
hippocampus .q-u 2704 to 2841 139 to 2     also hits gene zubar 138/156
(88 %)
0 diff
(100 %id)
CR607999 Neuroblastoma Cot 25-normalized .q-u 2716 to 3618 1 to 903   tiling clone,   903/903
(100 %)
0 diff
(100 %id)
BX333662 Neuroblastoma Cot 25-normalized .q-u 2716 to 3615 1 to 900       900/903
(99 %)
4 diff
(99.6 %id)
BM705773 eye, lens .q-u 2756 to 3186 1 to 431   fully sequenced,   431/431
(100 %)
0 diff
(100 %id)
AA421921 ovarian tumor, ovary .q-u 2763 to 3328 1 to 566       566/566
(100 %)
0 diff
(100 %id)
BM692116 eye, human retina .q-u 2793 to 3214 2 to 423   fully sequenced,   422/423
(99 %)
5 diff
(98.9 %id)
N78444 multiple sclerosis lesions .q-u 2881 to 3098 1 to 218       218/218
(100 %)
0 diff
(100 %id)
AA076142   .q-u 2882 to 3211 1 to 330       330/330
(100 %)
0 diff
(100 %id)
AA372494 colon .q-u 2888 to 3223 1 to 339       339/339
(100 %)
5 diff
(98.6 %id)
AW963596   .q-u 2889 to 3612 1 to 724   AAA   724/724
(100 %)
1 diff
(99.9 %id)
BQ574474 Chondrosarcoma Grade II, Left Pelvis .q-u 2890 to 3612 740 to 19   AAA   722/722
(100 %)
1 diff
(99.9 %id)
AA432392   .q-u 2892 to 3212 1 to 321       321/321
(100 %)
0 diff
(100 %id)
FN112755 breast carcinoma .q-u 2902 to 2978 8 to 83       76/84
(90 %)
2 diff
(97.7 %id)
DA108023 cerebellum .q-u 2922 to 3493 2 to 574   capped   573/573
(100 %)
1 diff
(99.9 %id)
FN159896 breast carcinoma .q-u 2934 to 3027 1 to 91       91/91
(100 %)
4 diff
(95.7 %id)
AU185148 skin .q-u 2944 to 3186 1 to 243       243/243
(100 %)
1 diff
(99.6 %id)
BG779599 adenocarcinoma, Prostate .q-u 2945 to 3606 1 to 667       667/705
(94 %)
12 diff
(98.3 %id)
CB157175 Liver .q-u 2956 to 3612 1 to 657   AAA   657/657
(100 %)
0 diff
(100 %id)
DV460482 cochlea, ear .q-u 2977 to 3588 1 to 608       608/618
(98 %)
41 diff
(93.4 %id)
TI_149313191   .q-u 2984 to 3612 720 to 92   AAA   629/921
(68 %)
29 diff
(96.9 %id)
BQ025101 placenta .q-u 3032 to 3612 599 to 19   AAA   581/589
(98 %)
0 diff
(100 %id)
DB314770   .q-u 3062 to 3612 551 to 1       551/551
(100 %)
0 diff
(100 %id)
BX363750   .q-u 3066 to 3580 518 to 1       936/1021
(91 %)
38 diff
(96.3 %id)
D79200 placenta .q-u 3071 to 3386 1 to 314       314/314
(100 %)
2 diff
(99.4 %id)
AU146655 whole embryo, mainly body .q-u 3072 to 3612 539 to 1       539/541
(99 %)
13 diff
(97.6 %id)
TI_158434980   .q-u 3077 to 3612 631 to 89   AAA   543/1121
(48 %)
55 diff
(95.1 %id)
R82773 placenta .q-u 3082 to 3468 1 to 397       397/404
(98 %)
19 diff
(95.3 %id)
N75778 cochlea, ear .q-u 3094 to 3272 18 to 197   fully sequenced,   180/197
(91 %)
5 diff
(97.5 %id)
AL696978 human skeletal muscle .q-u 3098 to 3529 1 to 432   AAA Possibly primed on the genome, locally A rich (11/11 A in genome downstream of last aligned base) 432/432
(100 %)
0 diff
(100 %id)
BF055556 pooled .q-u 3102 to 3611 510 to 1       510/510
(100 %)
0 diff
(100 %id)
AI741438 pooled .q-u 3110 to 3612 525 to 23   AAA   503/503
(100 %)
12 diff
(97.7 %id)
BF055104 pooled .q-u 3110 to 3611 502 to 1       502/502
(100 %)
0 diff
(100 %id)
BE463646 2 pooled Wilms' tumors, one primary and onemetastatic to brain, Kidney .q-u 3116 to 3612 497 to 1       497/497
(100 %)
0 diff
(100 %id)
BQ026126 placenta .q-u 3120 to 3612 510 to 18   AAA   493/493
(100 %)
3 diff
(99.4 %id)
BU949120 Pancreas, Purified pancreatic islet .q-u 3121 to 3614 495 to 1       495/495
(100 %)
9 diff
(98.2 %id)
EB387043 eye, optic nerve .q-u 3125 to 3612 1 to 488   AAA   488/488
(100 %)
0 diff
(100 %id)
AA909343 pooled .q-u 3126 to 3612 487 to 1       487/487
(100 %)
0 diff
(100 %id)
AI417751 Prostate .q-u 3134 to 3615 482 to 1       482/482
(100 %)
1 diff
(99.8 %id)
CF541230 lung .q-u 3136 to 3612 495 to 19   AAA   477/477
(100 %)
2 diff
(99.6 %id)
BF438876 pooled .q-u 3139 to 3530 397 to 6       392/397
(98 %)
0 diff
(100 %id)
AA431717   .q-u 3144 to 3613 470 to 1       470/470
(100 %)
3 diff
(99.4 %id)
AI685319 pooled .q-u 3145 to 3611 467 to 1       467/467
(100 %)
3 diff
(99.4 %id)
AI089204 pooled .q-u 3151 to 3611 461 to 1       461/461
(100 %)
0 diff
(100 %id)
BU734973 eye, lens .q-u 3156 to 3612 475 to 19   fully sequenced, AAA   457/457
(100 %)
0 diff
(100 %id)
AW293530   .q-u 3157 to 3612 473 to 18   AAA   456/456
(100 %)
15 diff
(96.8 %id)
AI913543 Kidney .q-u 3158 to 3612 455 to 1       455/455
(100 %)
0 diff
(100 %id)
AI589358 adenocarcinoma, Pancreas .q-u 3164 to 3613 450 to 1       450/450
(100 %)
1 diff
(99.8 %id)
AW117442 pooled .q-u 3164 to 3612 463 to 15   AAA   449/449
(100 %)
0 diff
(100 %id)
AI207154 pooled germ cell tumors .q-u 3165 to 3615 452 to 2       451/452
(99 %)
0 diff
(100 %id)
BQ022143 placenta .q-u 3165 to 3612 465 to 18   AAA   448/448
(100 %)
2 diff
(99.6 %id)
AI027914 parathyroid gland, parathyroid tumor .q-u 3166 to 3612 457 to 11   AAA   447/447
(100 %)
0 diff
(100 %id)
AI168260 pooled .q-u 3174 to 3611 438 to 1       438/438
(100 %)
2 diff
(99.6 %id)
AI298174 carcinoid, lung .q-u 3174 to 3611 438 to 1       438/438
(100 %)
0 diff
(100 %id)
AW511828 moderately-differentiated endometrialadenocarcinoma, 3 pooled tumors, uterus .q-u 3174 to 3613 440 to 1       440/440
(100 %)
0 diff
(100 %id)
BU728520 eye, human retina .q-u 3184 to 3612 447 to 19   fully sequenced, AAA   429/429
(100 %)
2 diff
(99.6 %id)
AA993455   .q-u 3195 to 3615 421 to 1       421/421
(100 %)
0 diff
(100 %id)
AI187332 lung .q-u 3203 to 3615 413 to 1       413/413
(100 %)
0 diff
(100 %id)
AI910711 Kidney .q-u 3203 to 3612 436 to 27   AAA   410/410
(100 %)
2 diff
(99.6 %id)
AW298250   .q-u 3208 to 3612 422 to 18   AAA   405/405
(100 %)
5 diff
(98.8 %id)
AI470479 pooled .q-u 3211 to 3611 404 to 1       404/405
(99 %)
3 diff
(99.3 %id)
AI374979   .q-u 3213 to 3615 403 to 1       403/403
(100 %)
0 diff
(100 %id)
AI671460 Kidney .q-u 3214 to 3615 402 to 1       402/402
(100 %)
0 diff
(100 %id)
AI239453 pooled .q-u 3216 to 3612 418 to 22   AAA   397/397
(100 %)
3 diff
(99.3 %id)
BF431726 pooled .q-u 3220 to 3613 394 to 1       394/394
(100 %)
0 diff
(100 %id)
AI049546   .q-u 3223 to 3612 390 to 1       390/390
(100 %)
0 diff
(100 %id)
FN149367 breast carcinoma .q-u 3238 to 3352 1 to 111       111/116
(95 %)
7 diff
(94.0 %id)
DB312352 thalamus .q-u 3240 to 3612 373 to 1       373/373
(100 %)
2 diff
(99.5 %id)
N22555 cochlea, ear .q-u 3242 to 3615 387 to 1   fully sequenced,   387/387
(100 %)
9 diff
(97.7 %id)
AA598811   .q-u 3245 to 3614 370 to 1       370/370
(100 %)
0 diff
(100 %id)
AA933011 carcinoid, lung .q-u 3247 to 3615 371 to 3       369/371
(99 %)
0 diff
(100 %id)
AL079899 uterus .q-u 3268 to 3559 12 to 303       292/292
(100 %)
3 diff
(99.0 %id)
AW021818.
matches multiple genes
cochlea, ear .q-u 3277 to 3612 1 to 336   AAA Possibly primed on the genome, locally A rich (13/13 A in genome downstream of last aligned base), also hits gene geesmeybu 336/336
(100 %)
5 diff
(98.6 %id)
AW662040 colon, moderately-differentiated adenocarcinoma .q-u 3282 to 3546 269 to 5       265/269
(98 %)
0 diff
(100 %id)
BI492747 cochlea, ear .q-u 3284 to 3612 346 to 18   AAA   329/336
(97 %)
0 diff
(100 %id)
AW183476 pooled .q-u 3285 to 3612 349 to 22   AAA   328/328
(100 %)
8 diff
(97.6 %id)
AW074380 colon, juvenile granulosa tumor .q-u 3297 to 3612 317 to 1       317/317
(100 %)
3 diff
(99.1 %id)
AW662045 colon, moderately-differentiated adenocarcinoma .q-u 3297 to 3546 256 to 5       252/256
(98 %)
0 diff
(100 %id)
AI270168 colon, moderately-differentiated adenocarcinoma .q-u 3303 to 3612 321 to 13   AAA   309/309
(100 %)
1 diff
(99.7 %id)
AA076048   .q-u 3326 to 3615 293 to 1       293/293
(100 %)
3 diff
(99.0 %id)
AA970240 pooled .q-u 3339 to 3612 274 to 1       274/274
(100 %)
0 diff
(100 %id)
BM148478 leukopheresis .q-u 3343 to 3610 294 to 27   AAA   268/270
(99 %)
7 diff
(97.5 %id)
FN072385 breast carcinoma .q-u 3366 to 3441 1 to 77       77/78
(98 %)
2 diff
(97.5 %id)
AW472859 moderately-differentiated endometrialadenocarcinoma, 3 pooled tumors, uterus .q-u 3375 to 3612 249 to 12   AAA   238/238
(100 %)
0 diff
(100 %id)
H88460 cochlea, ear .q-u 3393 to 3613 1 to 221   fully sequenced,   221/221
(100 %)
0 diff
(100 %id)
N90676 lung .q-u 3393 to 3613 222 to 1       222/244
(90 %)
6 diff
(97.6 %id)
R24049 placenta .q-u 3400 to 3612 228 to 16   AAA   213/213
(100 %)
0 diff
(100 %id)
AA056731 uterus .q-u 3408 to 3612 206 to 1       206/206
(100 %)
2 diff
(99.1 %id)
AI925056 poorly differentiated adenocarcinoma withsignet ring cell features, stomach .q-u 3456 to 3612 177 to 21   AAA   157/157
(100 %)
0 diff
(100 %id)
H88390 cochlea, ear .q-u 3480 to 3582 103 to 1   fully sequenced,   103/103
(100 %)
0 diff
(100 %id)
H00621 placenta .q-u 3487 to 3590 104 to 1       104/104
(100 %)
1 diff
(99.1 %id)
AA421922 ovarian tumor, ovary .q-u 3487 to 3596 111 to 2       110/111
(99 %)
0 diff
(100 %id)
AI052383   .q-u 3487 to 3610 124 to 1       124/124
(100 %)
4 diff
(96.8 %id)
BQ227323 embryonal carcinoma, cell line, testis .q-u 3504 to 3612 1 to 109   AAA   109/109
(100 %)
0 diff
(100 %id)
FN108284 breast carcinoma .q-u 3520 to 3610 1 to 91       91/94
(96 %)
1 diff
(99.0 %id)
GD160367   .q-u 3525 to 3612 1 to 88   AAA   88/88
(100 %)
3 diff
(96.6 %id)
CD657454 Embryonic Stem cells .r-u 1 to 813 9 to 813 exact tiling clone,   805/833
(96 %)
6 diff
(99.3 %id)
N29197.
matches multiple genes
melanocyte .r-u 177 to 495 1 to 320 exact tiling clone, also hits gene CHORDC1 320/321
(99 %)
3 diff
(99.1 %id)
CN256205 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .s 1 to 377 1 to 377 exact tiling clone,   377/377
(100 %)
0 diff
(100 %id)
DW425903 Liver .t-u 1 to 269 17 to 284   tiling clone,   268/284
(94 %)
6 diff
(97.9 %id)
DW462292 Liver .t-u 1 to 355 17 to 370 L7Y Q8R M10W D11I I12F ... tiling clone,   354/370
(95 %)
6 diff
(98.4 %id)
FN150485 breast carcinoma .u-u 1 to 117 1 to 117 exact tiling clone,   117/117
(100 %)
0 diff
(100 %id)
EH329656   .va 1 to 65 1 to 65 exact tiling clone,   65/66
(98 %)
1 diff
(98.5 %id)
CR936683 fetal kidney Gene TROVE2, variant not shown         Suspected internal deletion, this clone was ignored    
FN091066 breast carcinoma Gene TROVE2, variant not shown         Submitted on the opposite strand    
BG503271 embryonal carcinoma, testis Gene TROVE2, variant not shown         Suspected internal deletion, this clone was ignored    
DB047528 testis Gene TROVE2, variant not shown       capped This clone was ignored    
DB338316 testis Gene TROVE2, variant not shown         This clone was ignored    
? Gene Summary Gene on genome mRNA:.a, .b, .c, .d, .e, .f, .g, .h, .i, .j, .k, .l-u, .m, .n, .o, .p, .q-u, .r-u, .s, .t-u, .u-u, .va Alternative mRNAs features, proteins, introns, exons, sequences Expression Tissue Function, regulation, related genes DCI